Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ABCL — AbCellera Biologics Inc.

CIK 861177 NEW YORK, NY

Position in ABCL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$33,890,067
+$7,451,657 QoQ
Shares Held
4,317,206
-43.0% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 150 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority Sole 29% Shared 0% None 71%

Common Shares in ABCL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ABCL ranks #23 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABCL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,890,067 4,317,206
2026-03-31 $26,438,410 7,575,476
2025-12-31 $26,938,070 7,876,629
2025-06-30 $29,057,653 8,471,619
2025-03-31 $34,946,469 15,671,063
2024-12-31 $13,185,000 4,500,000
2024-09-30 $11,934,267 4,590,103
2024-06-30 $13,611,932 4,598,626
2022-06-30 $340,778 31,998